Neuroblastoma

Beta-blockers may boost chemo effect in childhood cancer

Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Journal of Cancer. Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Journal of Cancer.

22 May 2013

• Health & Medicine

The challenge of spotting cancers in children

Spotting childhood cancer early has a huge impact on how effectively that cancer can be treated - we cover the important signs for parents to watch out for. Spotting childhood cancer early has a huge impact on how effectively that cancer can be treated - we cover the important signs for parents to watch out for.

24 April 2013

More than 33,000 childhood cancer survivors living in the UK

An estimated 33,000 long-term survivors of childhood cancer - the vast majority of whom are cured - will be living in the UK by the end of 2012. An estimated 33,000 long-term survivors of childhood cancer - the vast majority of whom are cured - will be living in the UK by the end of 2012.

14 November 2012

• Health & Medicine

More than five thousand children saved since 70s thanks to better cancer treatment

At least 5,600 more children have survived for at least five years after being diagnosed with cancer than would have done if survival rates had remained as they were in the early 1970s, according to new statistics from Cancer Research UK. At least 5,600 more children have survived for at least five years after being diagnosed with cancer than would have done if survival rates had remained as they were in the early 1970s, according to new statistics from Cancer Research UK.

14 November 2011

• Science & Technology
• Health & Medicine

Treatment reduces dangerous side effects of cancer treatment in children

Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology. Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.

20 July 2010

• Health & Medicine

New trial brings pioneering treatment to children with cancer in the UK

10 December 2009

• Health & Medicine

New Cancer Research UK trial offers hope for childhood cancer

CHILDREN in the UK with a high risk form of the childhood cancer neuroblastoma are set to benefit from a new international clinical trial ї funded by Cancer Research UK - which uses immunotherapy to help prevent the disease from coming back. CHILDREN in the UK with a high risk form of the childhood cancer neuroblastoma are set to benefit from a new international clinical trial ї funded by Cancer Research UK - which uses immunotherapy to help prevent the disease from coming back.

10 December 2009

• Health & Medicine

Hope for pioneering immunotherapy treatment for childhood cancer

CANCER RESEARCH UK scientists at the University of Southampton have developed a potential new antibody treatment which, in the laboratory, shows significantly increased survival from neuroblastoma - a form of childhood cancer which grows from undeveloped tissue of the nervous system. It is hoped that it could one day be used to treat children with the disease. Their findings will be presented at the NCRI Cancer Conference in Birmingham. CANCER RESEARCH UK scientists at the University of Southampton have developed a potential new antibody treatment which, in the laboratory, shows significantly increased survival from neuroblastoma - a form of childhood cancer which grows from undeveloped tissue of the nervous system. It is hoped that it could one day be used to treat children with the disease. Their findings will be presented at the NCRI Cancer Conference in Birmingham.

5 October 2009

• Health & Medicine

Detailed diagnosis boosts child cancer survival

More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, according to research published in the Journal of Clinical Oncology*. More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, according to research published in the Journal of Clinical Oncology*.

6 March 2009

• Health & Medicine

Faster chemo technique increases survival in children with neuroblastoma

Chemotherapy given with shorter intervals between treatments than conventional chemotherapy increases survival rates by two thirds in children with high-risk neuroblastoma, according to a study published in the Lancet Oncology* today (Tuesday). Chemotherapy given with shorter intervals between treatments than conventional chemotherapy increases survival rates by two thirds in children with high-risk neuroblastoma, according to a study published in the Lancet Oncology* today (Tuesday).

26 February 2008